David W. J. McGirr

David W. J. McGirr

DirectoratINSMED· In proxies 2023–2025

David W. J. McGirr sits on 11 public boards.

Boards1

  • INSMEDDirector · 10 yr on the boardIndependentAudit (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. INSMEDPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +410%
  2. Rhythm PharmaceuticalsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Director, Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM)Public company
    • Director? – PresentNo stock prices for these years
  4. Director, Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) Director, X4 Pharmaceuticals, Inc. (Nasdaq: XFOR) Recent Public Board Service: Director until March 2020, Menlo Therapeutics Inc. (Nasdaq: MNLO) (name changed to VYNE Therapeutics Inc. (Nasdaq: VYNE))Public company
    • Director? – PresentNo stock prices for these years
  5. Director, X4 Pharmaceuticals, Inc. (Nasdaq: XFOR)Public company
    • Director? – PresentNo stock prices for these years
  6. X4 Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Menlo Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. VYNE Therapeutics Inc.Public company
    • Director? – PresentNo stock prices for these years
  9. Roka Bioscience, Inc.Public company · 5 yr
    • Director2013 – 2018 · 5 yrNo stock prices for these years
  10. Relypsa, Inc.Public company · 3 yr
    • Director2013 – 2016 · 3 yrNo stock prices for these years
  11. Galencia AG Cubist Pharmaceuticals, Inc.Public company · 12 yr
    • Director2002 – 2014 · 12 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?